A CIK cell and a preparation method and application thereof
A cell and nuclear cell technology, applied in the field of CIK cells and their preparation, can solve the problems of limited CIK cell activity maintenance time, limited time to exert effect, and many intermediate liquid replacement operations, so as to reduce the number of liquid replacement operations and survival time Effects of Prolongation, Type and Reduction of Working Concentration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Example 1: Technical process for the preparation of CIK cells of the present invention
[0036] (1) Isolation and culture of PBMC from tumor patients
[0037] Collect 5 mL of peripheral blood from malignant tumor patients after surgery or chemotherapy, separate PBMCs with human lymphocyte separation medium, and culture the cells in GT-T551 medium containing 10% fetal bovine serum, 100 units / mL penicillin and 100 μg / mL streptomycin ( Takara).
[0038] (2) Induce CIK cells
[0039] After PBMC cells were treated with 25ng / mL IL-7 for 48 hours, 1 μg / mL antiCD3 and 1 μg / mL antiCD28 were added at the same time, stimulated at a low concentration for 48 hours, and then 1 μg / mL antiCD95 was added to continue culture for 4 days.
[0040] CIK cells were obtained without changing medium in the middle.
Embodiment 2
[0041] Example 2: Detection of proliferation and activation effects of CIK cells
[0042] (1) IL-7 and antiCD95 synergistically stimulate the proliferation of PBMC cells in tumor patients
[0043] The PBMCs used in the cell proliferation experiment were labeled with CFSE, and the PBMCs were cultured in the dark. The CIK cells were prepared as described above. The control cells were stimulated with 1 μg / ml of antiCD3 and antiCD28 at low concentrations and then added with IgG control antibody. Cells were collected, loaded for flow cytometry detection, and the Proliferation function of Flowjo software was used to analyze the percentage of cell proliferation.
[0044] (2) IL-7 and antiCD95 synergistically stimulate T lymphocyte subsets and phenotype detection in PBMC of tumor patients.
[0045] CIK cells and controls were prepared in the same way as described above. After the cells were collected, they were stained with CD4, CD8, and CD45RA flow cytometry antibodies, and then flo...
Embodiment 3
[0047] Example 3: IL-7 and CD95 molecules co-stimulate the tumor killing activity detection of PBMC of tumor patients
[0048] 1. In vitro cell killing experiment of tumor cell lines
[0049] The MKN-45 gastric cancer-derived cell line was cultured in RMPI1640 medium containing 10% fetal bovine serum, 100 units / ml penicillin and 100 μg / ml streptomycin. When MKN-45 cells were cultured to the logarithmic growth phase, they were seeded in 96-well plates at a density of 1×10^4 per well and cultured overnight. CIK cells and controls were prepared as above. After 4 days, PBMC were collected and MKN-45 cells were plated overnight to synchronize.
[0050] PBMCs and MKN-45 were counted, and different numbers of PBMCs were added to the wells of the MKN-45 cell culture plate replaced with serum-free medium, so that the ratio of the number of PBMCs to MKN-45 (effector to target ratio, E / T ratio) is 0.5:1, 1:1, 2:1, 4:1, 16:1 and other gradients.
[0051] In order to avoid the impact of ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



